Let Them Talk: Coping with PrEP-Related Stigma and Sustaining PrEP Persistence Among Men Who Have Sex with Men in Tanga, Tanzania
Abstract
1. Introduction
2. Materials and Methods
2.1. Design
2.2. Participants and Sampling
2.3. Ethical Considerations
2.4. Data Collection
2.5. Data Analysis
2.6. Quality and Rigor
3. Results
3.1. Participants Characteristics
3.2. Socially Constructed Stigma Around PrEP
3.2.1. PrEP Care as a HIV Care
“These pills look like ARVs, so when someone sees you with them, they just assume you have HIV. And the clinic we go to is the same one used by people living with HIV. In Tanga everyone knows everyone, so when someone sees you there, they say you also have HIV. I know there’s a difference because when HIV clients collect their pills, they have to scan their fingerprints, but I don’t. Still, you can’t defend yourself once they’ve seen you; they already believe you have HIV and they go tell others that you have HIV.”(P 18)
3.2.2. PrEP as a ‘Gay’ Pill
“Sister, you should know that out here in the streets, people call these pills pills for ‘mashoga’ and prostitutes. So the moment someone sees you with them, they automatically assume you’re the one being penetrated by other manly guys. For us who share a room in a ghetto, it becomes really hard to even use them… where would you even keep the pills? The moment your boys see them, the news spreads that you are being penetrated”(P7)
3.2.3. PrEP as a Marker of Promiscuity and Sexual Recklessness
“You can have your main partner, someone who’s really taking care of you, and when they see the pills they say, ‘I’m with you alone so why are you taking these pills? If it’s just me and you, or do you have other men out there and you are just using me for your personal gains?’”(P3)
3.2.4. PrEP as a Magnet for HIV
“I’ve been on PrEP for a year, but the way people talk is that if I stop now and get exposed to HIV, I’ll get it more easily than someone who never took the pills. It’s like these pills have some kind of chemical that attracts HIV. So if you plan to quit, you better quit early. But if you continue, then you just have to stick with it, no turning back…”(P24)
3.2.5. PrEP as a Pill That Harms Bodily Organs
“Me, I’m still taking them, but honestly sometimes you hear so many things… it makes you pause. Like, what if? Even if I don’t fully believe it, it stays in your mind”(P4)
3.3. Persistence Protective Mental Processes Amidst the Stigma
3.3.1. Personal Agency
“Everyone talks and each person says their own thing. But if you know why you’re using it you have to calm your mind and say ‘Let them talk and as for me, I’ll keep going, the choice is yours no one makes it for you…you just have to have a clear mind and not easily swayed”(P23)
3.3.2. Mental Time Travel
“I want to become a doctor so I can give people education, But when you have HIV, you’re constantly worrying, what if people find out? You lose your peace. You start feeling like maybe you won’t achieve your dreams. But with PrEP, I know I’m protected. Every month I test, I check my health, and I feel strong. I’m using my pills, I’m okay and I’m happy. I feel joy all the time because I know my dreams are valid”(P6)
3.4. Affirming Social Connections as External Reinforcement
“For me, I have two people I told that I am using and they really encouraged me. They’d tell me ‘If you’ve decided to use the medications, then continue. If you keep thinking about what others are saying, your life will never move forward. Stand on your ground because you’re not a child anymore. If that is your decision, own it.’”(P14)
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| AIDS | Acquired immune deficiency syndrome |
| ARV/ARVs | Antiretroviral drug(s) |
| COVID-19 | Coronavirus disease 2019 |
| DOCEHTA | Strengthening Doctoral Education for Health in Tanzania |
| DRC | Democratic Republic of the Congo |
| HIV | Human immunodeficiency virus |
| IRB | Institutional Review Board |
| MUHAS | Muhimbili University of Health and Allied Sciences |
| NORAD | Norwegian Programme for Capacity Development in Higher Education and Research for Development |
| PrEP | Pre-exposure prophylaxis |
| REC | Research Ethics Committee |
| UNAIDS | Joint United Nations Programme on HIV/AIDS |
| WHO | World Health Organisation |
References
- Joint United Nations. Programme on HIV/AIDS (UNAIDS). AIDS, Crisis and the Power to Transform: UNAIDS Global AIDS Update 2025; UNAIDS: Geneva, Switzerland, 2025. [Google Scholar]
- The Global Fund. Results Report 2025; The Global Fund: Geneva, Switzerland, 2025; Available online: https://www.theglobalfund.org/en/results/ (accessed on 20 September 2025).
- World Health Organization. Global Health Observatory Data: HIV/AIDS; WHO: Geneva, Switzerland, 2024; Available online: https://www.who.int/data/gho/data/themes/hiv-aids (accessed on 20 September 2025).
- Oldenburg, C.E.; Perez-Brumer, A.G.; Reisner, S.L.; Mimiaga, M.J.; Hatzenbuehler, M.L.; Bärnighausen, T. Human rights protections and HIV prevalence among MSM who sell sex: Cross-country comparisons from a systematic review and meta-analysis. Glob. Public Health 2018, 13, 414–425. [Google Scholar] [CrossRef]
- Jin, H.; Restar, A.J.; Beyrer, C.; Tang, W. Epidemiological conditions of HIV among key populations in Nairobi, Kenya: Implications for HIV prevention, treatment and care. PLoS ONE 2021, 16, e0253450. [Google Scholar] [CrossRef]
- Schweitzer, A.M.; Dišković, A.; Krongauz, V.; Newman, J.; Tomažič, J.; Yancheva, N. Addressing HIV stigma in healthcare, community, and legislative settings in Central and Eastern Europe. AIDS Res. Ther. 2023, 20, 87. [Google Scholar] [CrossRef]
- Stoebenau, K.; Muchanga, G.; Ahmad, S.S.; Bwalya, C.; Mwale, M.; Toussaint, S.; Maambo, C.; Peters, C.J.; Baumhart, C.; Mwango, L.K.; et al. Barriers and facilitators to uptake and persistence on prep among key populations in Southern Province, Zambia: A thematic analysis. BMC Public Health 2024, 24, 1617. [Google Scholar] [CrossRef]
- Bandura, A. Social Foundations of Thought and Action: A Social Cognitive Theory; Prentice-Hall: Englewood Cliffs, NJ, USA, 1986. [Google Scholar]
- Donnell, D.; Baeten, J.M.; Bumpus, N.N.; Brantley, J.; Bangsberg, D.R.; Haberer, J.E.; Mujugira, A.; Mugo, N.; Ndase, P.; Hendrix, C.; et al. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J. Acquir. Immune Defic. Syndr. 2014, 66, 340–348. [Google Scholar] [CrossRef]
- Nicol, M.R.; Adams, J.L.; Kashuba, A.D. HIV PrEP trials: The road to success. Clin. Investig. 2013, 3. [Google Scholar] [CrossRef]
- Dimitrov, D.T.; Mâsse, B.R.; Donnell, D. PrEP adherence patterns strongly affect individual HIV risk and observed efficacy in randomized clinical trials. J. Acquir. Immune Defic. Syndr. 2016, 72, 444–451. [Google Scholar] [CrossRef]
- Chapin-Bardales, J.; Haaland, R.; Martin, A.; Holder, A.; Butts, V.A.; Sionean, C.; Sey, E.K.; Brady, K.A.; Raymond, H.F.; Opoku, J.; et al. HIV Pre-exposure Prophylaxis Persistence and Adherence Among Men Who Have Sex with Men in Four US Cities. J. Acquir. Immune Defic Syndr. 2023, 93, 34–41. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Shangase, N.; Jiyane, A.; Buthelezi, F.; O’Connor, C.; Brown, B.; Rees, K. Pre-exposure prophylaxis persistence at two sites in an integrated primary health care programme in South Africa. Front. Public Health 2025, 13, 1460180. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Rao, A.; Mhlophe, H.; Pretorius, A.; Mcingana, M.; Mcloughlin, J.; Shipp, L.; Baral, S.; Hausler, H.; Schwartz, S.; Lesko, C. Effect of implementation strategies on pre-exposure prophylaxis persistence among female sex workers in South Africa: An interrupted time series study. Lancet HIV 2023, 10, e807–e815. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ongolly, K.; Dolla, A.; Ngure, K.; Irungu, E.M.; Odoyo, J.; Wamoni, E.; Peebles, K.; Mugwanya, K.; Mugo, N.R.; Bukusi, E.A.; et al. “I Just Decided to Stop:” Understanding PrEP Discontinuation Among Individuals Initiating PrEP in HIV Care Centers in Kenya. J. Acquir. Immune Defic. Syndr. 2021, 87, e150–e158. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Pico-Espinosa, O.J.; Hull, M.; MacPherson, P.; Grace, D.; Gaspar, M.; Lachowsky, N.; Mohammed, S.; Demers, J.; Kilduff, M.; Truong, R.; et al. PrEP-related stigma and PrEP use among gay, bisexual and other men who have sex with men in Ontario and British Columbia, Canada. AIDS Res. Ther. 2022, 19, 49. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Davoudpour, S.; Phillips, G.L., II; Serrano, P.A.; French, A.L.; Hosek, S.G. A Memo on Factors Associated with Perception of Stigma Attached to PrEP: Evidence from the Keeping It LITE Study. Sexes 2024, 5, 300–316. [Google Scholar] [CrossRef]
- Psaros, C.; Hill-Rorie, J.; Quint, M.; Horvitz, C.; Dormitzer, J.; Biello, K.B.; Krakower, D.S.; Safren, S.A.; Mimiaga, M.J.; Sullivan, P.; et al. A qualitative exploration of how to support PrEP adherence among young men who have sex with men. AIDS Care 2024, 36, 732–743. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Link, B.G.; Phelan, J.C. Conceptualizing stigma. Annu. Rev. Sociol. 2001, 27, 363–385. [Google Scholar] [CrossRef]
- Dubov, A.; Galbo, P., Jr.; Altice, F.L.; Fraenkel, L. Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study. Am. J. Mens. Health 2018, 12, 1843–1854. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Tuan, L.A.; Pham, L.Q.; Khuyen, T.T.; Hao, B.M.; Hoa, N.T.P.; Vu, K.-D.; Lien, T.H.M.; Duyen, P.T.T.; Phan, H.T.; Giang, L.M.; et al. Facilitators and Barriers to Hiv Pre-Exposure Prophylaxis Adherence and Retention Among Young Men Who have Sex With Men: A Meta-Ethnographic Scoping Review. AIDS Behav. 2025, 29, 1075–1088. [Google Scholar] [CrossRef]
- Rosengren, A.L.; Lelutiu-Weinberger, C.; Woodhouse, E.W.; Sandanapitchai, P.; Hightow-Weidman, L.B. A Scoping Review of HIV Pre-exposure Prophylaxis Stigma and Implications for Stigma-Reduction Interventions for Men and Transwomen Who Have Sex with Men. AIDS Behav. 2021, 25, 2054–2070, Erratum in AIDS Behav. 2021, 25, 3046. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Earnshaw, V.A.; Chaudoir, S.R. From conceptualizing to measuring HIV stigma: A review of HIV stigma mechanism measures. AIDS Behav. 2009, 13, 1160–1177. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Tisdell, E.J.; Merriam, S.B.; Stuckey-Peyrot, H.L. Qualitative Research: A Guide to Design and Implementation; John Wiley & Sons: Hoboken, NJ, USA, 2025. [Google Scholar]
- Braun, V.; Clarke, V. Toward good practice in thematic analysis: Avoiding common problems and be(com)ing a knowing researcher. Int. J. Transgend Health 2022, 24, 1–6. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Lincoln, Y.; Guba, E.G. Naturalistic Inquiry; Sage: Newbury Park, CA, USA, 1985. [Google Scholar]
- Goffman, E. Stigma: Notes on the Management of Spoiled Identity; Prentice-Hall: Englewood Cliffs, NJ, USA, 1963. [Google Scholar]
- Moen, K.; Aggleton, P.; Leshabari, M.T.; Middelthon, A.L. Gays, Guys, and Mchicha Mwiba: Same-Sex Relations and Subjectivities in Dar es Salaam. J. Homosex. 2014, 61, 511–539. [Google Scholar] [CrossRef] [PubMed]
- Shio, J.; Moyer, E. Navigating norms of masculinity: Tactical gender performances among gay men in Dar Es Salaam, Tanzania. Gend. Place Cult. 2020, 28, 853–869. [Google Scholar] [CrossRef]
- Pachankis, J.E.; Bränström, R. How many sexual minorities are hidden? Projecting the size of the global closet with implications for policy and public health. PLoS ONE 2019, 14, e0218084. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Pachankis, J.E.; Hatzenbuehler, M.L.; Hickson, F.; Weatherburn, P.; Berg, R.C.; Marcus, U.; Schmidt, A.J. Hidden from health: Structural stigma, sexual orientation concealment, and HIV across 38 countries in the European MSM Internet Survey. AIDS 2015, 29, 1239–1246. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Gios, L.; Mirandola, M.; Sherriff, N.; Toskin, I.; Blondeel, K.; Dias, S.; Staneková, D.; Folch, C.; Schink, S.B.; Nöstlinger, C.; et al. Being in the Closet. Correlates of Outness Among MSM in 13 European Cities. J. Homosex. 2021, 68, 415–433. [Google Scholar] [CrossRef] [PubMed]
- Kerr, J.; Ayangeakaa, S.; Bullock, N.A.; Burton, K.; Combs, R.; Harris, L.; Sterrett-Hong, E.; Rozema, I.; Sears, J.; Northington, T. A qualitative exploration of various stigmas impacting HIV pre-exposure prophylaxis (PrEP) uptake among African American young adults. Fam. Community Health 2022, 45, 218–227. [Google Scholar] [CrossRef]
- Lichtwarck, H.O.; Massawe, E.P.; Mmbaga, E.J.; Moen, K. What can PrEP do for female sex workers? Unpacking the “effectosphere” of biomedical HIV prevention in Dar es Salaam. Soc. Sci. Med. 2024, 358, 117245. [Google Scholar] [CrossRef]
- Adeagbo, O.; Harrison, S.; Qiao, S.; Li, X. Pre-exposure prophylaxis (PrEP) uptake among black men who have sex with men (BMSM) in the Southern US. Int. J. Environ. Res. Public Health 2021, 18, 9715. [Google Scholar] [CrossRef]
- Alie, M.S.; Abebe, G.F.; Negesse, Y.; Adugna, A.; Girma, D. Vaccine hesitancy in context of COVID-19 in East Africa: Systematic review and meta-analysis. BMC Public Health 2024, 24, 2796. [Google Scholar] [CrossRef]
- Ochola, E.A. Vaccine hesitancy in Sub-Saharan Africa in the Context of COVID-19 vaccination exercise: A systematic review. Diseases 2023, 11, 32. [Google Scholar] [CrossRef]
- Graybill, L.A.; McKay, C.N.; Wang, J.; Sam-Agudu, N.A.; Yotebieng, M.; Saidi, F.; Bekker, L.G.; Shook-Sa, B.E.; Chi, B.H.; Rosenberg, N.E. Characterizing populations prioritized for PrEP in 19 African countries: A review of national guidance. J. Int. AIDS Soc. 2025, 28, e26407. [Google Scholar] [CrossRef] [PubMed]
- Kigombola, A.; Lyimo, J.; Mizinduko, M.; Mkembela, D.; Maziku, E.; Kafura, W.; Maghimbi, A.; Musanhu, C.; Nsubuga, P.; Yoti, Z. Low engagement of key populations in HIV health services in Tanzania: Analysis of community, legal and policy factors. Pan Afr. Med. J. 2023, 45, 8. [Google Scholar] [CrossRef] [PubMed]
- Kiondo, F.; Metta, E.; Mmbaga, E.J.; Leshabari, M.T.; Swai, C.; Mbotwa, C.H.; Moen, K. Retention in HIV Pre-Exposure Prophylaxis Among Men Who Have Sex with Men in Tanga, Tanzania. HIV AIDS 2025, 17, 185–194. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Zotova, N.; Shongo, A.; Lelo, P.; Mbonze, N.; Kaba, D.; Ntangu, P.; Shi, Q.; Adedimeji, A.; Anastos, K.; Yotebieng, M.; et al. Attrition from Care and Barriers to PrEP Use Among Key Populations in Kinshasa, DRC: A Multiple Methods Study. AIDS Behav. 2025, 29, 3673–3686. [Google Scholar] [CrossRef]
- Golub, S.A.; Fikslin, R.A.; Goldberg, M.H.; Peña, S.M.; Radix, A. Predictors of PrEP Uptake Among Patients with Equivalent Access. AIDS Behav. 2019, 23, 1917–1924. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Golub, S.A.; Starbuck, L.; Fikslin, R.; Gamarel, K.E. Psychometric Evaluation and Predictive Validity of an Adapted Adherence Self-Efficacy Scale for PrEP. AIDS Behav. 2023, 27, 218–230. [Google Scholar] [CrossRef] [PubMed]
- Whiteley, L.; Craker, L.; Sun, S.; Tarantino, N.; Hershkowitz, D.; Moskowitz, J.; Arnold, T.; Haubrick, K.; Olsen, E.; Mena, L.; et al. Factors associated with PrEP adherence among MSM living in Jackson, Mississippi. J. HIV AIDS Soc. Serv. 2021, 20, 246–261. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Bauermeister, J.A.; Downs, J.S.; Krakower, D.S. PrEP product acceptability and dual process decision-making among men who have sex with men. Curr. HIV/AIDS Rep. 2020, 17, 161–170. [Google Scholar] [CrossRef]
- Ireland, M.E.; Schwartz, H.A.; Chen, Q.; Ungar, L.H.; Albarracín, D. Future-oriented tweets predict lower county-level HIV prevalence in the United States. Health Psychol. 2015, 34S, 1252–1260. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Murphy, L.; Dockray, S. The consideration of future consequences and health behaviour: A meta-analysis. Health Psychol. Rev. 2018, 12, 357–381. [Google Scholar] [CrossRef] [PubMed]
- Gichane, M.W.; Velloza, J.; Hosek, S.; Beauchamp, G.; Anderson, P.; Delany-Moretlwe, S.; Celum, C. Hoping to Adhere? Examining the Relationship Between Hope and Pre-exposure Prophylaxis Willingness, Adherence, and Persistence Among Young Women in South Africa and Zimbabwe (HPTN 082). AIDS Behav. 2025, 29, 527–534. [Google Scholar] [CrossRef] [PubMed]
- Brooks, R.A.; Cabral, A.; Nieto, O.; Fehrenbacher, A.; Landrian, A. Experiences of Pre-Exposure Prophylaxis Stigma, Social Support, and Information Dissemination Among Black and Latina Transgender Women Who Are Using Pre-Exposure Prophylaxis. Transgend. Health 2019, 4, 188–196. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Sheira, L.A.; Kwena, Z.A.; Ayieko, B.; Charlebois, E.D.; Agot, K.; Gutin, S.A.; Lewis-Kulzer, J.; Olugo, P.; Gandhi, M.; Bukusi, E.A.; et al. The effect of a social network-based intervention on adherence to HIV preexposure prophylaxis and HIV viral suppression among Kenyan fishermen. AIDS 2025, 39, 912–917. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Rugira, E.; Biracyaza, E.; Umubyeyi, A. Uptake and Persistence on HIV Pre-Exposure Prophylaxis Among Female Sex Workers and Men Having Sex with Men in Kigali, Rwanda: A Retrospective Cross-Sectional Study Design. Patient Prefer. Adherence 2023, 17, 2353–2364. [Google Scholar] [CrossRef] [PubMed]
| Variable | Category | n (%) |
|---|---|---|
| PrEP persistence Status | Not persistent | 18 (56%) |
| Persistent | 14 (44%) | |
| Marital Status | Single | 21 (66%) |
| Married to women | 6 (19%) | |
| Cohabiting with male partner | 5 (16%) | |
| Sexual position identity | Top | 9 (28%) |
| Versatile | 8 (26)% | |
| Bottom | 15 (46%) | |
| Age Group | 18–24 years | 12 (38%) |
| 25–34 years | 15 (47%) | |
| 35+ years | 5 (16%) | |
| Education Level | Primary or below | 13 (41%) |
| Secondary | 15 (47%) | |
| Tertiary | 4 (13%) | |
| Occupation | Motorcycle driver (bodaboda) | 9 (28%) |
| Small business/vendor | 11 (34%) | |
| Student | 6 (19%) | |
| Unemployed | 6 (19%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Kiondo, F.; Metta, E.; Mmbaga, E.J.; Moen, K.; Swai, C.; Leshabari, M. Let Them Talk: Coping with PrEP-Related Stigma and Sustaining PrEP Persistence Among Men Who Have Sex with Men in Tanga, Tanzania. Healthcare 2026, 14, 259. https://doi.org/10.3390/healthcare14020259
Kiondo F, Metta E, Mmbaga EJ, Moen K, Swai C, Leshabari M. Let Them Talk: Coping with PrEP-Related Stigma and Sustaining PrEP Persistence Among Men Who Have Sex with Men in Tanga, Tanzania. Healthcare. 2026; 14(2):259. https://doi.org/10.3390/healthcare14020259
Chicago/Turabian StyleKiondo, Faithness, Emmy Metta, Elia John Mmbaga, Kåre Moen, Calvin Swai, and Melkzedeck Leshabari. 2026. "Let Them Talk: Coping with PrEP-Related Stigma and Sustaining PrEP Persistence Among Men Who Have Sex with Men in Tanga, Tanzania" Healthcare 14, no. 2: 259. https://doi.org/10.3390/healthcare14020259
APA StyleKiondo, F., Metta, E., Mmbaga, E. J., Moen, K., Swai, C., & Leshabari, M. (2026). Let Them Talk: Coping with PrEP-Related Stigma and Sustaining PrEP Persistence Among Men Who Have Sex with Men in Tanga, Tanzania. Healthcare, 14(2), 259. https://doi.org/10.3390/healthcare14020259

